The cancer which survived: Insights from the genome of an 11000 year-old cancer

Current Opinion in Genetics and Development

Volumn 30, Issue , 2015, Pages 49-55

  Strakova, Andrea ^a   Murchison, Elizabeth P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ANIMAL VENEREAL TUMOR; CANCER CELL; CANCER GENETICS; CANINE TRANSMISSIBLE VENEREAL TUMOR; CELL LINEAGE; DISEASE TRANSMISSION; EVOLUTIONARY ADAPTATION; GENETIC VARIABILITY; GENOME ANALYSIS; HORIZONTAL GENE TRANSFER; HUMAN; MOLECULAR EVOLUTION; NATURAL SELECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR ESCAPE; ANIMAL; DOG; DOG DISEASE; GENETICS; NEOPLASM; TRANSMISSION; VETERINARY;

CANIS FAMILIARIS;

ANIMALS; DOG DISEASES; DOGS; NEOPLASMS; TUMOR ESCAPE;

EID: 84926339517     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2015.03.005     Document Type: Review

References (63)

1. Murchison E.P., Wedge D.C., Alexandrov L.B., Fu B., Martincorena I., Ning Z., Tubio J.M., Werner E.I., Allen J., De Nardi A.B., et al. Transmissible dog cancer genome reveals the origin and history of an ancient cell lineage. Science 2014, 343:437-440.
2. Murgia C., Pritchard J.K., Kim S.Y., Fassati A., Weiss R.A. Clonal origin and evolution of a transmissible cancer. Cell 2006, 126:477-487.
3. Rebbeck C.A., Thomas R., Breen M., Leroi A.M., Burt A. Origins and evolution of a transmissible cancer. Evolution 2009, 63:2340-2349.
4. Blaine D.P. A domestic treatise on the diseases of horses and dogs. London. T. Boosey 1810.
5. Katzir N., Rechavi G., Cohen J.B., Unger T., Simoni F., Segal S., Cohen D., Givol D. "Retroposon" insertion into the cellular oncogene c-myc in canine transmissible venereal tumor. Proc Natl Acad Sci USA 1985, 82:1054-1058.
6. Nowinsky M.A. On the question of innoculation of malignant neoplasms (experimental study) (from Russian). Arkhiv Veterinarskikh Nauk 1877, 7:129-163.
7. Weber W.T., Nowell P.C., Hare W.C. Chromosome studies of a transplanted and a primary canine venereal sarcoma. J Natl Cancer Inst 1965, 35:537-547.
8. Strakova A., Murchison E.P. The changing global distribution and prevalence of canine transmissible venereal tumour. BMC Vet Res 2014, 10:168.
9. Thomas R., Rebbeck C., Leroi A.M., Burt A., Breen M. Extensive conservation of genomic imbalances in canine transmissible venereal tumors (CTVT) detected by microarray-based CGH analysis. Chromosome Res 2009, 17:927-934.
10. Marchal T., Chabanne L., Kaplanski C., Rigal D., Magnol J.P. Immunophenotype of the canine transmissible venereal tumour. Vet Immunol Immunopathol 1997, 57:1-11.
11. Mozos E., Mendez A., Gomez-Villamandos J.C., Martin De Las Mulas J., Perez J. Immunohistochemical characterization of canine transmissible venereal tumor. Vet Pathol 1996, 33:257-263.
12. Stratton M.R., Campbell P.J., Futreal P.A. The cancer genome. Nature 2009, 458:719-724.
13. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
14. Cohen D. The canine transmissible venereal tumor: a unique result of tumor progression. Adv Cancer Res 1985, 43:75-112.
15. Ganguly B., Das U., Das A.K. Canine transmissible venereal tumour: a review. Vet Comp Oncol 2013, 10.1111/vco.12060.
16. Perez J., Bautista M.J., Carrasco L., Gomez-Villamandos J.C., Mozos E. Primary extragenital occurrence of transmissible venereal tumors: three case reports. Canine Pract 1994, 19:7-10.
17. Ginel P.J., Molleda J.M., Novales M., Martin E., Margarito J.M., Lopez R. Primary transmissible venereal tumor in the nasal cavity of a dog. Vet Rec 1995, 136:222-223.
18. Brown N.O., Calvert C., MacEwen E.G. Chemotherapeutic management of transmissible venereal tumors in 30 dogs. J Am Vet Med Assoc 1980, 176:983-986.
19. Thacher C., Bradley R.L. Vulvar and vaginal tumors in the dog: a retrospective study. J Am Vet Med Assoc 1983, 183:690-692.
20. Canine Transmissible Venereal Tumor: Etiology, Pathology, Diagnosis and Treatment 2005, International Veterinary Information Service, Ithaca, NY. M.I. Mello Martins, F. Ferreira de Souza, C. Gobello (Eds.).
21. Pearse A.M., Swift K. Allograft theory: transmission of devil facial-tumour disease. Nature 2006, 439:549.
22. Hamede R.K., McCallum H., Jones M. Biting injuries and transmission of Tasmanian devil facial tumour disease. J Anim Ecol 2013, 82:182-190.
23. Banfield W.G., Woke P.A., Mackay C.M., Cooper H.L. Mosquito transmission of a reticulum cell sarcoma of hamsters. Science 1965, 148:1239-1240.
24. Brindley D.C., Banfield W.G. A contagious tumor of the hamster. J Natl Cancer Inst 1961, 26:949-957.
25. Cooper H.L., Mackay C.M., Banfield W.G. Chromosome studies of a contagious reticulum cell sarcoma of the Syrian hamster. J Natl Cancer Inst 1964, 33:691-706.
26. Kauffman H.M., McBride M.A., Cherikh W.S., Spain P.C., Delmonico F.L. Transplant tumor registry: donors with central nervous system tumors. Transplantation 2002, 73:579-582.
27. Gartner H.V., Seidl C., Luckenbach C., Schumm G., Seifried E., Ritter H., Bultmann B. Genetic analysis of a sarcoma accidentally transplanted from a patient to a surgeon. N Engl J Med 1996, 335:1494-1496.
28. Tolar J., Neglia J.P. Transplacental and other routes of cancer transmission between individuals. J Pediatr Hematol Oncol 2003, 25:430-434.
29. Sala-Torra O., Hanna C., Loken M.R., Flowers M.E., Maris M., Ladne P.A., Mason J.R., Senitzer D., Rodriguez R., Forman S.J., et al. Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transpl 2006, 12:511-517.
30. Moore A.E., Rhoads C.P., Southam C.M. Homotransplantation of human cell lines. Science 1957, 125:158-160.
31. Strauss D.C., Thomas J.M. Transmission of donor melanoma by organ transplantation. Lancet Oncol 2010, 11:790-796.
32. Rosenberg A.S., Singer A. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 1992, 10:333-358.
33. Hsiao Y.W., Liao K.W., Hung S.W., Chu R.M. Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells. Vet Immunol Immunopathol 2002, 87:19-27.
34. Siddle H.V., Kreiss A., Tovar C., Yuen C.K., Cheng Y., Belov K., Swift K., Pearse A.M., Hamede R., Jones M.E., et al. Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer. Proc Natl Acad Sci USA 2013, 110:5103-5108.
35. Cohen D., Shalev A., Krup M. Lack of beta 2-microglobulin on the surface of canine transmissible venereal tumor cells. J Natl Cancer Inst 1984, 72:395-401.
36. Yang T.J., Chandler J.P., Dunne-Anway S. Growth stage dependent expression of MHC antigens on the canine transmissible venereal sarcoma. Br J Cancer 1987, 55:131-134.
37. Algarra I., Collado A., Garrido F. Altered MHC class I antigens in tumors. Int J Clin Lab Res 1997, 27:95-102.
38. Brown G.K., Kreiss A., Lyons A.B., Woods G.M. Natural killer cell mediated cytotoxic responses in the Tasmanian devil. PLoS One 2011, 6:e24475.
39. Hsiao Y.W., Liao K.W., Hung S.W., Chu R.M. Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-beta 1 and restores the lymphokine-activated killing activity. J Immunol 2004, 172:1508-1514.
40. Hsiao Y.W., Liao K.W., Chung T.F., Liu C.H., Hsu C.D., Chu R.M. Interactions of host IL-6 and IFN-gamma and cancer-derived TGF-beta1 on MHC molecule expression during tumor spontaneous regression. Cancer Immunol Immunother 2008, 57:1091-1104.
41. Liu C.C., Wang Y.S., Lin C.Y., Chuang T.F., Liao K.W., Chi K.H., Chen M.F., Chiang H.C., Chu R.M. Transient downregulation of monocyte-derived dendritic-cell differentiation, function, and survival during tumoral progression and regression in an in vivo canine model of transmissible venereal tumor. Cancer Immunol Immunother 2008, 57:479-491.
42. Cohen D. The biological behaviour of the transmissible venereal tumour in immunosupressed dogs. Eur J Cancer 1973, 9:253-258.
43. Yang T.J., Jones J.B. Canine transmissible venereal sarcoma: transplantation studies in neonatal and adult dogs. J Natl Cancer Inst 1973, 51:1915-1918.
44. Epstein R.B., Bennett B.T. Histocompatibility typing and course of canine venereal tumors transplanted into unmodified random dogs. Cancer Res 1974, 34:788-793.
45. Karlson A.G., Mann F.C. The transmissible venereal tumor of dogs: observations on forty generations of experimental transfers. Ann N Y Acad Sci 1952, 54:1197-1213.
46. Wade H. An experimental investigation of infective sarcoma of the dog, with a consideration of its relationship to cancer. J Pathol Bacteriol 1908, 12:384-425.
47. Amber E.I., Henderson R.A., Adeyanju J.B., Gyang E.O. Single-drug chemotherapy of canine transmissible venereal tumor with cyclophosphamide, methotrexate, or vincristine. J Vet Intern Med 1990, 4:144-147.
48. Bellingham Smith G., Washbourn J.W. Infective venereal tumours in dogs. J Pathol Bacteriol 1898, 5:99-110.
49. Taylor Bennett B., Taylor Y., Epstein R. Segregation of the clinical course of transmissible venereal tumor with DL-A haplotypes in canine families. Transpl Proc 1975, 7:503-505.
50. Alexandrov L.B., Nik-Zainal S., Wedge D.C., Aparicio S.A., Behjati S., Biankin A.V., Bignell G.R., Bolli N., Borg A., Borresen-Dale A.L., et al. Signatures of mutational processes in human cancer. Nature 2013, 500:415-421.
51. Campbell P.J., Pleasance E.D., Stephens P.J., Dicks E., Rance R., Goodhead I., Follows G.A., Green A.R., Futreal P.A., Stratton M.R. Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc Natl Acad Sci USA 2008, 105:13081-13086.
52. Ju Y.S., Alexandrov L.B., Gerstung M., Martincorena I., Nik-Zainal S., Ramakrishna M., Davies H.R., Papaemmanuil E., Gundem G., Shlien A., et al. Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer. Elife 2014, 3.
53. McFarland C.D., Korolev K.S., Kryukov G.V., Sunyaev S.R., Mirny L.A. Impact of deleterious passenger mutations on cancer progression. Proc Natl Acad Sci USA 2013, 110:2910-2915.
54. Sofuni T., Makino S. A supplementary study on the chromosomes of veneral tumors of the dog. Gann 1963, 54:149-154.
55. Adey A., Burton J.N., Kitzman J.O., Hiatt J.B., Lewis A.P., Martin B.K., Qiu R., Lee C., Shendure J. The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line. Nature 2013, 500:207-211.
56. Rebbeck C.A., Leroi A.M., Burt A. Mitochondrial capture by a transmissible cancer. Science 2011, 331:303.
57. Spees J.L., Olson S.D., Whitney M.J., Prockop D.J. Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci USA 2006, 103:1283-1288.
58. Tan A.S., Baty J.W., Dong L.F., Bezawork-Geleta A., Endaya B., Goodwin J., Bajzikova M., Kovarova J., Peterka M., Yan B., et al. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. Cell Metab 2015, 21:81-94.
59. Keeling P.J., Palmer J.D. Horizontal gene transfer in eukaryotic evolution. Nat Rev Genet 2008, 9:605-618.
60. Gladyshev E.A., Meselson M., Arkhipova I.R. Massive horizontal gene transfer in bdelloid rotifers. Science 2008, 320:1210-1213.
61. Boschetti C., Carr A., Crisp A., Eyres I., Wang-Koh Y., Lubzens E., Barraclough T.G., Micklem G., Tunnacliffe A. Biochemical diversification through foreign gene expression in bdelloid rotifers. PLoS Genet 2012, 8:e1003035.
62. Poulin R. Parasite manipulation of host personality and behavioural syndromes. J Exp Biol 2013, 216:18-26.
63. de Brito C.P., de Oliveira C.M., Soares F.A., Faustino M., de Oliveira C.A. Immunohistochemical determination of estrogen receptor-alpha in vaginal and tumor tissues of healthy and TVT-affected bitches and their relation to serum concentrations of estradiol-17beta and progesterone. Theriogenology 2006, 66:1587-1592.